// App-Quantinova.ai

: Assessing the Impact of Minimally Invasive Liver Surgery in the Overweight and Obese: An International Multicenter Propensity Score Matched Analysis

Researchers

Presenter

  • G. Zimmitti

Principal Investigators

  • J. Sijberden

  • A. Ferrero

  • B. Edwin

  • U. Cillo

  • L. Aldrighetti

  • S. Lopez-Ben

  • F. Rotellar

  • D. Fuks

  • M. D'Hondt

  • J. Primrose

  • M. Vivarelli

  • A. Ruzzenente

  • M.G. Besselink

  • A. Alseidi

  • M. Efanov

  • F. Giuliante

  • M. Abu Hilal

Medical Centers

  • University of Verona, School of Medicine, General and Hepatobiliary Surgery, Department of Surgery and Oncology, Italy

  • Clinica Universidad de Navarra, Department of General and Digestive Surgery, Pamplona, Spain

  • University Hospital Southampton NHS Foundation Trust, Department of Surgery, United Kingdom

  • Università Cattolica del Sacro Cuore-IRCCS, Chirurgia Epatobiliare, Italy

  • Oslo University Hospital and Institute of Medicine, The Intervention Centre and Department of HPB Surgery, Norway

  • Groeninge Hospital, Department of Digestive and Hepatobiliary/Pancreatic Surgery, Kortrijk, Belgium

  • IRCCS San Raffaele Hospital, Hepatobiliary Surgery Division, Milan, Italy

  • Umberto I Mauriziano Hospital, Department of General and Oncological Surgery, Turin, Italy

  • Institut Mutualiste Montsouris, Department of Digestive, Oncologic and Metabolic Surgery, France

  • Fondazione Poliambulanza Instituto Ospedaliero, Department of Surgery, Brescia, Italy

  • University of California, San Francisco, United States

  • Hospital Doctor Josep Trueta de Girona, Servei de Cirurgia General i Digestiva, Spain

  • Padova University Hospital, Department of Surgery, Oncology and Gastroenterology, Italy

  • Virginia Mason Medical Center, Department of Surgery, Seatle, United States

  • Cancer Center Amsterdam, Amsterdam, Netherlands

  • Moscow Clinical Research Centre, Department of Hepato-Pancreato-Biliary Surgery, Russian Federation

  • Riuniti Hospital, Polytechnic University of Marche, Department of Experimental and Clinical Medicine, Italy

Locations

  • Italy

  • Spain

  • United States

  • United Kingdom

  • Norway

  • Belgium

  • Netherlands

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Obesity

Biomarkers

  • Folate Hydrolase 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

  • Multicenteric

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved